Patents

Topical Formulation for Raynaud’s Phenomenon

This patented composition contains nitroglycerin, oleic acid, alpha hydroxy acid and an emollient.

Author Image

By: Christine Esposito

Editor-in-Chief

Raynaud's syndrome phenomena in adult hand.

US Patent No.12,070,440 B2 (Edward T. Kisak, John M. Newsam, R. Dominic King-Smith); Permeautus, Inc., Del Mar, CA, has patented a pharmaceutically-acceptable topical composition for treating conditions such as Raynaud’s phenomenon in which peripheral blood flow in a subject is compromised. The composition is comprised at least 4% weight by weight of nitroglycerin, at least 8% oleic acid, 1.425-1.575% of an emollient comprising a fatty acid ester of an alpha hydroxy acid, 2.85 -3.15% of...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters